Consequently, the affection of BDNF/TrkB signaling in muscles with ALS disease deregulates presynaptic molecules—including PKCs and their targets—which could decrease synaptic activity, and therefore, the synaptic protection, and retrogradely affect MNs (Figure 2 and Figure 3). This evidence concerns the gene BDNF and amyotrophic lateral sclerosis.